(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 100.70%7.77M | 84.04%-705.12K | 73.40%-7.86M | 82.16%-2.13M | 43.87%-5.19M | 194.15%3.87M | -3.74%-4.42M | -3,103.22%-29.56M | -1,782.15%-11.95M | -3,107.71%-9.24M |
Net income from continuing operations | -92.83%7.47M | -1,703.01%-19.84M | 732.87%98.27M | 62.98%-3.01M | 46.37%-1.75M | 3,646.18%104.13M | 8.96%-1.1M | -914.50%-15.53M | -1,701.25%-8.13M | -201.47%-3.25M |
Operating gains losses | -98.33%3.51K | 91.27%-10.22K | -93.22%190.95K | 86.29%-12.49K | -94.14%110.34K | -85.67%210.27K | 73.57%-117.17K | 1,142.62%2.82M | -607.42%-91.08K | 802.52%1.88M |
Depreciation and amortization | 2,093.35%12.52K | 2,080.91%12.45K | 1,578.02%25.96K | 5,756.27%23.84K | 142.47%982 | 40.64%571 | 73.56%571 | --1.55K | --407 | --405 |
Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.98M | ---- | ---- |
Unrealized gains and losses of investment securities | 102.09%2.19M | --19.13M | -31,083.58%-104.68M | --0 | --0 | ---104.68M | --0 | ---335.7K | ---145.96K | --0 |
Remuneration paid in stock | -8.07%161.22K | -68.67%61.15K | -72.70%326.38K | -45.39%125.29K | -151.09%-169.48K | -45.75%175.37K | -37.22%195.19K | 147.04%1.2M | 264.87%229.43K | -21.20%331.73K |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --655.44K | --0 | ---- |
Change In working capital | -151.00%-2.06M | 98.17%-62.06K | 91.80%-2M | 107.57%740.86K | 58.75%-3.38M | 236.18%4.04M | -0.38%-3.4M | -23,612.94%-24.35M | -3,604.31%-9.79M | -5,171.79%-8.2M |
-Change in receivables | 109.86%32.72K | 267.51%377.87K | -1,090.88%-444.94K | -299.85%-192.7K | 2,376.96%305.26K | -926.82%-331.93K | -615.79%-225.58K | 188.64%44.9K | 370.95%96.42K | 181.75%12.32K |
-Change in prepaid assets | -110.73%-10.37K | 128.47%61.95K | -77.20%58.09K | -86.08%82.8K | -50.17%96.26K | -54.20%96.61K | 70.76%-217.57K | 164.60%254.77K | 250.83%594.84K | --193.16K |
-Change in payables and accrued expense | -183.40%-653.94K | 685.62%682.66K | 308.04%226.45K | 280.35%310.26K | -61.77%60.05K | 76.92%-230.75K | -90.41%86.89K | -131.79%-108.85K | -203.87%-172.03K | -11.14%157.05K |
-Change in other current assets | -538.66%-1.57M | 95.59%-134K | 67.59%-7.93M | 92.24%-800K | 55.11%-3.84M | 88.56%-245.68K | 11.85%-3.04M | ---24.47M | ---10.31M | ---8.56M |
-Change in other current liabilities | ---11.73K | ---12.07K | 270.24%110.17K | --110.17K | --0 | --0 | --0 | ---64.72K | --0 | --0 |
-Change in other working capital | -96.83%150.78K | ---1.04M | --5.98M | --1.23M | ---- | --4.75M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 100.70%7.77M | 84.04%-705.12K | 73.40%-7.86M | 82.16%-2.13M | 43.87%-5.19M | 194.15%3.87M | -3.74%-4.42M | -3,103.22%-29.56M | -1,782.15%-11.95M | -3,107.71%-9.24M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 99.89%-1.82K | -1.75K | 70.29%-1.78M | -162.26K | -19.78K | -1.6M | 0 | -16.95%-6M | 0 | 0 |
Net PPE purchase and sale | ---1.82K | ---1.63K | -2,403.29%-158.91K | ---139.13K | ---19.78K | --0 | --0 | ---6.35K | --0 | --0 |
Net business purchase and sale | --0 | ---- | 73.30%-1.6M | --0 | --0 | ---1.6M | ---- | -49.80%-5.99M | --0 | --0 |
Net investment purchase and sale | ---- | ---119 | ---23.13K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 99.89%-1.82K | ---1.75K | 70.29%-1.78M | ---162.26K | ---19.78K | ---1.6M | --0 | -16.95%-6M | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -8.93%-954.22K | 82.64%-36.65K | -152.93%-1.89M | 42.89%-155.31K | 45.20%-647.05K | -597.35%-876.01K | -104.10%-211.09K | -93.29%3.57M | -100.70%-271.94K | -108.18%-1.18M |
Net common stock issuance | -8.93%-954.22K | 82.64%-36.65K | -19.71%-1.89M | 42.89%-155.31K | 45.20%-647.05K | -597.35%-876.01K | ---211.09K | -103.05%-1.58M | -100.73%-271.94K | -108.18%-1.18M |
Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 3.63%202.73K | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 279.15%4.95M | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -8.93%-954.22K | 82.64%-36.65K | -152.93%-1.89M | 42.89%-155.31K | 45.20%-647.05K | -597.35%-876.01K | -104.10%-211.09K | -93.29%3.57M | -100.70%-271.94K | -108.18%-1.18M |
Net cash flow | ||||||||||
Beginning cash position | -92.20%667.39K | -89.16%1.4M | -72.53%12.92M | -84.55%3.84M | -73.09%9.96M | -79.87%8.56M | -72.53%12.92M | --47.02M | 93.84%24.84M | --37.01M |
Current changes in cash | 387.93%6.82M | 83.94%-743.52K | 63.94%-11.54M | 79.95%-2.45M | 43.83%-5.85M | 132.95%1.4M | 9.39%-4.63M | -167.80%-31.99M | -135.78%-12.22M | -180.01%-10.42M |
Effect of exchange rate changes | -291.76%-5.05K | -96.25%10.22K | 100.83%17.48K | -95.85%12.46K | 84.60%-270.22K | 100.21%2.63K | -56.12%272.62K | -1,228.59%-2.11M | 504.96%299.81K | -741.02%-1.75M |
End cash Position | -24.91%7.48M | -92.20%667.39K | -89.16%1.4M | -89.16%1.4M | -84.55%3.84M | -73.09%9.96M | -79.87%8.56M | -72.53%12.92M | -72.53%12.92M | 93.84%24.84M |
Free cash from | 100.65%7.77M | 84.01%-706.75K | 72.87%-8.02M | 80.99%-2.27M | 43.65%-5.21M | 194.15%3.87M | -3.59%-4.42M | -3,103.90%-29.57M | -1,782.15%-11.95M | -3,107.71%-9.24M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data